Complete Stereochemical Elucidation of Teixobactin

Bacterial resistance to antibiotics is rising at an alarming rate, and with only two new classes of antibiotics being developed since the 1960s, time is of the essence.

Novobiotic Pharmaceuticals stepped up to the challenge by identifying new natural compounds produced by previously “unculturable” bacteria found in marine and soil environments. Novobiotic Pharmaceuticals then contracted Eurofins Discovery and their DiscoveryOne™ integrated drug discovery team for assistance.

Download this case study to discover:

• The details of this successful collaboration and how Novobiotic Pharmaceuticals identified new natural compounds.
• How the DiscoveryOne team was able to elucidate the complete stereochemical structure of teixobactin.
• How DiscoveryOne team helped Novobiotic secure two National Institutes of Health (NIH) grants.